ULTRAGENYX PHARMACEUTICAL INC. Reports Q1 2026 Financial Results
2026-05-06SEC Filing 10-Q (0001193125-26-206960)
Please check the link below for details.
Ticker mentioned:RARE
Source:Original SEC Document β
Please check the link below for details.